Supplementary Tables 1 Through 4 from AZD2014, an Inhibitor of Mtorc1 and Mtorc2, is Highly Effective in ER+ Breast Cancer when Administered Using Intermittent or Continuous Schedules
openalex(2023)
Key words
Cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined